# Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

> **NCT00297739** · PHASE4 · COMPLETED · sponsor: **Armenteros, Jorge L., M.D., P.A.** · enrollment: 25 (—)

## Conditions studied

- Aggression

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00297739
- **Lead sponsor:** Armenteros, Jorge L., M.D., P.A.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 25 (—)
- **Last updated:** 2006-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297739, "Risperidone Augmentation for Treatment-Resistant Aggression in ADHD". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00297739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*